Key Events This Week
6 Apr: Week opens at Rs.1,694.20
7 Apr: Stock rises 1.43% to Rs.1,718.50
8 Apr: Slight dip of 0.29% amid strong Sensex rally
9 Apr: Marginal gain of 0.22% with heavy call option activity
10 Apr: Sharp decline of 3.65% amid heavy put option and open interest surge
6 April 2026: Week Opens Steady Amid Market Stability
Sun Pharmaceutical Industries Ltd began the week at Rs.1,694.20, with a traded volume of 1,00,284 shares. The Sensex closed at 33,229.93, setting a stable backdrop for the week ahead. No significant price movement was recorded on this day, establishing a baseline for subsequent trading sessions.
7 April 2026: Stock Gains 1.43% Outperforming Sensex
The stock advanced by Rs.24.30, or 1.43%, closing at Rs.1,718.50 on 7 April. This gain outpaced the Sensex’s 0.50% rise to 33,395.05, reflecting positive investor sentiment early in the week. However, the volume dropped sharply to 31,284 shares, indicating cautious participation despite the price rise.
8 April 2026: Minor Correction Amid Strong Market Rally
On 8 April, Sun Pharma slipped 0.29% to Rs.1,713.60, a modest decline despite the Sensex surging 3.88% to 34,690.59. The stock’s volume surged to 2,29,390 shares, suggesting active trading amid profit-booking or sector rotation. This divergence hinted at early signs of relative weakness compared to the broader market.
9 April 2026: Marginal Recovery with Heavy Call Option Activity
The stock edged up 0.22% to Rs.1,717.35, while the Sensex retreated 0.49% to 34,521.99. Notably, 9 April saw significant call option volumes at the 1700 strike price expiring 28 April, with 4,721 contracts traded, indicating bullish positioning in the derivatives market. Despite this, the underlying equity showed limited upside, trading below all key moving averages and signalling short-term technical weakness.
Our current Stock of the Month is out! This Large Cap from Automobiles - Passenger Cars emerged as the single best opportunity from our elite universe. Get the details now!
- - Current monthly selection
- - Single best opportunity
- - Elite universe pick
10 April 2026: Sharp Decline Amid Heavy Put Option and Open Interest Surge
Sun Pharmaceutical Industries Ltd experienced a significant drop of 3.65% to close at Rs.1,654.70, touching an intraday low of Rs.1,645.45. This decline occurred despite the Sensex gaining 1.40% to 35,004.96, underscoring the stock’s underperformance. The day was marked by intense put option activity, with the 1660 strike put option leading volumes at 3,749 contracts and a turnover exceeding ₹451 lakhs, signalling bearish sentiment and hedging.
Simultaneously, open interest surged by 10.5%, rising from 79,459 to 87,813 contracts, accompanied by a futures volume of 57,104 contracts. This spike in derivatives activity amid falling prices suggests increased short positioning or volatility hedging by market participants. The stock traded below all major moving averages, reinforcing the technical weakness observed.
Despite the price pressure, Sun Pharma recorded a high traded volume of 3,39,144 shares and a value turnover exceeding ₹29,149.7 lakhs, reflecting strong institutional interest and liquidity. Delivery volumes, however, declined by 2.36% to 22.36 lakh shares, indicating some reduction in long-term investor participation.
Want to dive deeper on Sun Pharmaceutical Industries Ltd? There's a real-time research report diving right into the fundamentals, valuations, peer comparison, financials, technicals and much more!
- - Real-time research report
- - Complete fundamental analysis
- - Peer comparison included
Weekly Price Performance: Sun Pharma vs Sensex
| Date | Stock Price | Day Change | Sensex | Day Change |
|---|---|---|---|---|
| 2026-04-06 | Rs.1,694.20 | - | 33,229.93 | - |
| 2026-04-07 | Rs.1,718.50 | +1.43% | 33,395.05 | +0.50% |
| 2026-04-08 | Rs.1,713.60 | -0.29% | 34,690.59 | +3.88% |
| 2026-04-09 | Rs.1,717.35 | +0.22% | 34,521.99 | -0.49% |
| 2026-04-10 | Rs.1,654.70 | -3.65% | 35,004.96 | +1.40% |
Key Takeaways from the Week
Underperformance Despite Market Rally: Sun Pharma’s 2.33% weekly decline contrasted sharply with the Sensex’s 5.34% gain, reflecting stock-specific challenges amid a broadly positive market environment.
Heavy Derivatives Activity: The week saw intense call and put option trading, with call options signalling bullish bets at the 1700 strike and put options indicating bearish hedging near 1660 and 1600 strikes. The 10.5% surge in open interest underscores heightened market positioning and potential volatility ahead of expiry.
Technical Weakness: The stock consistently traded below all major moving averages, signalling sustained short- to long-term weakness. Mixed technical indicators, including mildly bullish daily MACD but bearish monthly signals, reflect a complex outlook.
Strong Institutional Interest and Liquidity: Despite price pressure, high traded volumes and value turnover indicate robust liquidity and active institutional participation, though delivery volumes declined slightly, suggesting some caution among long-term holders.
Mojo Score and Rating Upgrade: The company’s Mojo Score of 72.0 and recent upgrade to a Buy rating on 23 February 2026 highlight positive medium-term fundamentals, contrasting with near-term price softness.
Overall, Sun Pharmaceutical Industries Ltd’s week was characterised by a tug-of-war between fundamental strength and technical weakness, with derivatives markets reflecting both bullish and bearish sentiments. Investors should monitor open interest trends and price action closely as expiry approaches, balancing the company’s large-cap stature and upgraded rating against the current volatility and underperformance.
Limited Period Only. Get Started for only Rs. 16,999 - Get MojoOne for 2 Years + 1 Year Absolutely FREE! (72% Off) Get 72% Off →
